Bacillus subtilis DE111 partially reverses endothelial dysfunction in western-diet fed mice
Beneficial Microbes · 03.12.2024 · 16 (3) · 311-327
DOI: 10.1163/18762891-bja00052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beneficial Microbes, erschienen am 03.12.2024. Verfasst von B D Risk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA. Hauptthemen laut MEDLINE: Bacillus subtilis, Probiotics, Diet, Western, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Imbalances in the gut microbiome have emerged as an important factor in endothelial dysfunction, a significant risk factor for cardiovascular disease. Thus, interventions targeting the microbiome may prove helpful in preventing or reversing this impairment. We previously reported that spore-forming Bacillus subtilis DE111 improved endothelial function in a cohort of healthy, non-obese humans after a four-week intervention. Building on these promising results, the present study sought to investigate whether administering B. subtilis DE111 could reverse endothelial dysfunction in mice with diet-induced obesity. Male C57BL/6J mice were fed a Western diet (WD; n = 24) or standard diet (SD; n = 24) for ten weeks to induce endothelial dysfunction, after which half of the animals in each group (n = 12) were allocated to receive B. subtilis DE111 (hereafter, PB) formulated into the diet for an additional eight weeks. Outcomes included endothelial-dependent arterial dilation, glucose tolerance, body weight changes, microbiota profiles, and assessments of intestinal permeability and mucosal immunity markers. Furthermore, a cell culture model of gut barrier function was used to assess the effects of PB on gut barrier integrity. PB treatment significantly attenuated WD-induced mesenteric endothelial-dependent arterial dilation, independent of changes in other cardiometabolic parameters or changes in gut barrier function. In vitro trans-epithelial electrical resistance of the Caco-2 cell culture confirmed that neither PB-conditioned media nor faecal waters from B. subtilis -treated human stool resulted in gut barrier improvements, nor did they protect against inflammation-associated barrier disruptions. Unsurprisingly, microbiota analysis revealed significant differences in Shannon’s alpha diversity of WD-fed animals compared to SD. These data suggest that PB consumption significantly attenuated WD diet-induced endothelial dysfunction; however, the underlying mechanisms of this protection were not determined. Improvement in endothelial function was independent of PB-mediated changes to body weight or gut barrier function. Further studies should explore B. subtilis -mediated immune responses or metabolite production as mechanisms underlying these endothelial protective effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Food Science and Human Nutrition, 3447Colorado State University, Fort Collins, CO 80523-1571, USA.
ORCID-Profile: B D Risk
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Risk, B. D., Graham, E. L., Zhang, M., Wei, Y., Stark, G. C., Brown, G. D., Gentile, C. L., & Weir, T. L. (2024). Bacillus subtilis DE111 partially reverses endothelial dysfunction in western-diet fed mice. Beneficial Microbes, 16(3), 311-327. https://doi.org/10.1163/18762891-bja00052
Vancouver
Risk BD, Graham EL, Zhang M, Wei Y, Stark GC, Brown GD, et al. Bacillus subtilis DE111 partially reverses endothelial dysfunction in western-diet fed mice. Beneficial Microbes. 2024;16(3):311-327. doi:10.1163/18762891-bja00052
BibTeX
@article{Risk2024,
author = {Risk, B D and Graham, E L and Zhang, M and Wei, Y and Stark, G C and Brown, G D and Gentile, C L and Weir, T L},
title = {Bacillus subtilis DE111 partially reverses endothelial dysfunction in western-diet fed mice},
journal = {Beneficial Microbes},
year = {2024},
volume = {16},
number = {3},
pages = {311--327},
doi = {10.1163/18762891-bja00052}
}
EUVIMED